Philippe Monteyne - Profile and Investment Details

Investor Profile

Philippe Monteyne is a Venture Capital, Private Equity Firm based in Brussels, Flanders, Belgium with a diverse investment portfolio that includes companies such as NOVADIP Biosciences S.A., HealthTech For Care, PHMBIO+, Ona Therapeutics, eTheRNA immunotherapies, Indigo Diabetes, Accure Therapeutics, Confo Therapeutics, AltamarCAM Partners, Escala Therapeutics, Sagitta Biotech, Aelin Therapeutics, Fondation Plan Alzheimer France, Horama, ExeVir, Minoryx Therapeutics, Ogeda SAAelix Therapeutics, Bioxodes, Coave Therapeutics, ExeVir Bio, Op2Lysis, Egle Therapeutics, Immunic, Promethera Biosciences, OCTIMET Oncology, Leem, BIOASTER, ITeos Therapeutics, . Over time, Philippe Monteyne has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Philippe Monteyne is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Investment Management, Life Science, Small and Medium Businesses, Due Diligence Services, Diabetes, Business Development, Biotechnology, Entrepreneurship, Genomics, Neuroscience, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Philippe Monteyne, as their portfolio suggests a familiarity and interest in this area.

Understanding Philippe Monteyne’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.